Article

Aneurysmascreening in Risikogruppen: Sinnvoll?

Der Radiologe (impact factor: 0.61). 04/2012; 42(11):880-884. DOI:10.1007/s00117-002-0818-y pp.880-884

ABSTRACT Aneurysmascreening in Risikogruppen wird kontrovers diskutiert. Eindeutige Empfehlungen existieren z. Z. nicht. Ein Screening
bei Patienten mit familiären Aneurysmen erscheint nicht empfehlenswert. Patienten mit einer polyzystischen Nierendegeneration
(ADPKD) und bereits familiären SAB-Fällen sollten jedoch bei einer Prävalenz von 25% intrakranieller Aneurysmen alle 2–3 Jahre
mittels MRT-Angiographie untersucht werden.

There is a controversy discussion on screening for aneurysms in risk groups. True guidelines do not exist so far. It seems
that screening for familial aneurysms is not advisable today. But adult dominant polycystic kidney disease (ADPKD) patients
with a familial history of SAH should be screened because of a high prevalence rate of 25% for intracranial aneurysms in this
population. Screening should be performed every 2 to 3 years by MRI angiography in this special risk group.

0 0
 · 
0 Bookmarks
 · 
22 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

3 years
 
adult dominant polycystic kidney disease
 
Aneurysmascreening
 
controversy discussion
 
Eindeutige Empfehlungen existieren z. Z. nicht
 
mittels MRT-Angiographie untersucht werden
 
MRI angiography
 
prevalence rate
 
Risikogruppen wird kontrovers diskutiert
 
Screening
 
True guidelines
 

T Struffert